Promising Growth Stocks Worth Watching - May 24th
Read Our Latest Research Report on BLK
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
NVO stock traded down $0.91 during midday trading on Friday, reaching $67.26. 6,502,571 shares of the company’s stock traded hands, compared to its average volume of 6,685,864. Novo Nordisk A/S has a fifty-two week low of $57.00 and a fifty-two week high of $148.15. The business has a 50-day moving average price of $66.31 and a two-hundred day moving average price of $83.07. The company has a market capitalization of $301.83 billion, a P/E ratio of 20.44, a PEG ratio of 0.90 and a beta of 0.65. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.74 and a quick ratio of 0.55.
Read Our Latest Research Report on NVO
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
NYSE:BX traded down $0.70 during mid-day trading on Friday, hitting $136.23. The company had a trading volume of 2,608,968 shares, compared to its average volume of 3,786,373. The business has a fifty day simple moving average of $137.02 and a 200-day simple moving average of $160.55. The firm has a market capitalization of $99.40 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 1.07 and a beta of 1.67. The company has a current ratio of 0.67, a quick ratio of 0.71 and a debt-to-equity ratio of 0.61. Blackstone has a 1 year low of $115.66 and a 1 year high of $200.96.
